Jing. Z. Lin
President & CEO, Co-founder

Ph.D. U Toronto, Canada (1996); Postdoc, U Montana (1996-1998), Postdoc, UC Riverside (1998-2000). Dr. Lin previously worked as a senior scientist at Lynx Therapeutics, California, USA (2000-2002). He was a co-founder & CEO of Taitai Genomics Co., Ltd., Shenzhen, China (2002-2006), and was the founder/President of SignalDT Biosystems LLC, California, USA (2006-2013). Dr. Lin authored over 30 scientific papers and is an inventor of over 40 patents. 

Qian Jinhong
Chief Operating Officer

Ph.D., Univ. Nebraska, Postdoc, UC Berkeley. Dr. Qian previously served as a senior scientist at Incyte Genomics, California, USA, a senior vice president of BioMart, California, USA, and VP at SignalDT Biosystems, Californian, USA.  He is an author of more than 30 scientific papers and book chapters, and an inventor of over 30 patents. 

Li Shaoji
Director of R&D

Ph.D., University of Ghent, Belgium, postdoctoral fellow, University of Tennessee, USA. He used to be an assistant researcher at Gachon Medical University in South Korea and a researcher at the Korean Center for Disease Control (CDC). Published 4 SCI papers. Shenzhen "Peacock Project" overseas high-level C-class talents.

Huang Zhiyi
Chief Financial Officer

Master degree from Lancaster University, UK. He used to be the business director of Hong Kong Standard Chartered Bank and China CITIC Bank; the general manager of Shenzhen Aitejian Technology Co., Ltd.; the investment director of Hanyuan Group; the partner of Shenzhen Zhongmei Venture Capital. Good at corporate strategic planning and capital operation, long-term attention and research on industry dynamics and investment strategies in the field of biomedicine